{"id":9127,"date":"2018-08-02T13:50:57","date_gmt":"2018-08-02T13:50:57","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=9127"},"modified":"2026-03-30T13:40:46","modified_gmt":"2026-03-30T08:10:46","slug":"non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/","title":{"rendered":"Chronic Pain Management: Path to USD 10 Billion+ Opportunity"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Owing to the rapid onset of their medicinal effect, which offers immediate relief with high efficacy, opioids are still considered to be one of the most widely used pharmacological interventions for the management of moderate to severe forms of pain. However, these drugs are known to induce a euphoric state upon intake, often causing patients to abuse them; increased recreational use of opioids has also been shown to lead to drug addiction. In a recent article, published in 2017, 11.5 million individuals were reported to have been caught misusing prescription opioids, while over 42,000 died from opioid overdose, in the US alone. The opioid crisis has prompted drug manufacturers to develop non-addictive, non-narcotic-based therapeutics \/ analgesics for chronic pain management.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>The unmet need related to effective non-opioid narcotic therapies for the chronic pain management is evident across social media and various other online information portals.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>With 8 approved <a href=\"https:\/\/www.healthline.com\/health\/chronic-pain\">drugs<\/a> and over 140 clinical \/ preclinical candidates, the market for non-opioid chronic pain management solutions is growing at a commendable pace<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"431\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Management-Development-Pipeline-Roots.webp\" alt=\"As per Roots Analysis, the Non-Opioids for chronic pain management is fragmented across marketed, clinical and discovery pipeline. Further, it is worth highlighting that there are currently 8 drugs that are commercially available in market.\" class=\"wp-image-18049\" style=\"object-fit:contain;width:800px;height:513px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Management-Development-Pipeline-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Management-Development-Pipeline-Roots-300x192.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Companies with marketed drugs are also considering various life cycle management strategies in order to prolong the revenue generation potential of proprietary products.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Over time, several device-based pain management solutions have also emerged as viable alternatives to narcotic drugs \/ therapies.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Companies have raised over USD 1.5 billion in financing as investors have realized numerous benefits and future potential of non-opioid alternatives to chronic pain<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"432\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Funding-and-Investments-Roots.webp\" alt=\"Stakeholders are consistently demonstrating a heightened interest in investing in the non-opioids for chronic pain management market. It is noteworthy that over 50% of the funding has been secured through seed funding rounds.\" class=\"wp-image-18050\" style=\"object-fit:contain;width:800px;height:516px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Funding-and-Investments-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Funding-and-Investments-Roots-300x193.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>In the last six years, over 70 partnership agreements were inked between various industry stakeholders; majority of these were focused on commercialization and acquisitions<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"435\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Partnerships-and-Collaborations-Roots.webp\" alt=\"Various Industry and Non-industry players are inked various deals where over 25% of the partnerships were focused on commercial agreements.\" class=\"wp-image-18051\" style=\"object-fit:contain;width:800px;height:518px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Partnerships-and-Collaborations-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Partnerships-and-Collaborations-Roots-300x194.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Prevalent trends indicate that the market is likely to grow at a significant pace as multiple late stage molecules receive marketing approval in the foreseen future.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>The opportunity within the <a href=\"https:\/\/www.rootsanalysis.com\/reports\/chronic-pain-treatment-market\/212.html\">chronic pain treatment market<\/a> is likely to be distributed across various drug classes targeting a diverse array of disease indications; late stage drug candidates are anticipated to sustain long term growth<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"422\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Management-Market-Various-Drug-Classes-Roots.webp\" alt=\"The marker for non-opioids for chronic pain management is fragmented across various segments including drug class, indication and stage of development. \" class=\"wp-image-18052\" style=\"object-fit:contain;width:800px;height:499px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Management-Market-Various-Drug-Classes-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Management-Market-Various-Drug-Classes-Roots-300x188.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Chronic-Pain-Management-Market-Various-Drug-Classes-Roots-200x125.webp 200w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">To learn more, please click Chronic Pain Treatment Market. For any queries \/ suggestions, please do not hesitate to contact us at <a href=\"mailto:sales@rootsanalysis.com\">sales@rootsanalysis.com<\/a>. You can also download the\u00a0<a href=\"https:\/\/www.rootsanalysis.com\/reports\/212\/request-sample.html\">SAMPLE REPORT<\/a>\u00a0on chronic pain management by Roots Analysis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Our Social Media Platform<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Web:&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/\">https:\/\/www.rootsanalysis.com\/<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">LinkedIn:&nbsp;<a href=\"https:\/\/in.linkedin.com\/company\/roots-analysis\">https:\/\/in.linkedin.com\/company\/roots-analysis<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Twitter:&nbsp;<a href=\"https:\/\/twitter.com\/RootsAnalysis\">https:\/\/twitter.com\/RootsAnalysis<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Owing to the rapid onset of their medicinal effect, which offers immediate relief with high efficacy, opioids are still considered to be one of the most widely used pharmacological interventions for the management of moderate to severe forms of pain. However, these drugs are known to induce a euphoric state upon intake, often causing patients [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":19178,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[98,61],"tags":[249,250,248],"class_list":["post-9127","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","category-medical-devices-and-technology","tag-chronic-pain","tag-management-drugs","tag-non-opioids"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Chronic Pain Management: Path to USD 10 Billion and Opportunity<\/title>\n<meta name=\"description\" content=\"According to Roots Analysis, over 70 partnership agreements were inked between various players in the chronic pain management market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chronic Pain Management: Path to USD 10 Billion and Opportunity\" \/>\n<meta property=\"og:description\" content=\"According to Roots Analysis, over 70 partnership agreements were inked between various players in the chronic pain management market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-08-02T13:50:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-30T08:10:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/08\/Roots-Analysis-FeaturedImage-Pain.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"150\" \/>\n\t<meta property=\"og:image:height\" content=\"102\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Arun Gupta\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arun Gupta\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/\"},\"author\":{\"name\":\"Arun Gupta\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\"},\"headline\":\"Chronic Pain Management: Path to USD 10 Billion+ Opportunity\",\"datePublished\":\"2018-08-02T13:50:57+00:00\",\"dateModified\":\"2026-03-30T08:10:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/\"},\"wordCount\":380,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/Roots-Analysis-FeaturedImage-Pain.webp\",\"keywords\":[\"Chronic Pain\",\"Management Drugs\",\"Non-Opioids\"],\"articleSection\":[\"Healthcare\",\"Medical Devices and Technology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/\",\"name\":\"Chronic Pain Management: Path to USD 10 Billion and Opportunity\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/Roots-Analysis-FeaturedImage-Pain.webp\",\"datePublished\":\"2018-08-02T13:50:57+00:00\",\"dateModified\":\"2026-03-30T08:10:46+00:00\",\"description\":\"According to Roots Analysis, over 70 partnership agreements were inked between various players in the chronic pain management market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/Roots-Analysis-FeaturedImage-Pain.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/Roots-Analysis-FeaturedImage-Pain.webp\",\"width\":150,\"height\":102,\"caption\":\"This is a feature image for blog article Non-Opioids Chronic Pain Management at Roots Analysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chronic Pain Management: Path to USD 10 Billion+ Opportunity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\",\"name\":\"Arun Gupta\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"caption\":\"Arun Gupta\"},\"description\":\"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chronic Pain Management: Path to USD 10 Billion and Opportunity","description":"According to Roots Analysis, over 70 partnership agreements were inked between various players in the chronic pain management market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/","og_locale":"en_US","og_type":"article","og_title":"Chronic Pain Management: Path to USD 10 Billion and Opportunity","og_description":"According to Roots Analysis, over 70 partnership agreements were inked between various players in the chronic pain management market.","og_url":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2018-08-02T13:50:57+00:00","article_modified_time":"2026-03-30T08:10:46+00:00","og_image":[{"width":150,"height":102,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/08\/Roots-Analysis-FeaturedImage-Pain.webp","type":"image\/webp"}],"author":"Arun Gupta","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Arun Gupta","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/"},"author":{"name":"Arun Gupta","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62"},"headline":"Chronic Pain Management: Path to USD 10 Billion+ Opportunity","datePublished":"2018-08-02T13:50:57+00:00","dateModified":"2026-03-30T08:10:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/"},"wordCount":380,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/08\/Roots-Analysis-FeaturedImage-Pain.webp","keywords":["Chronic Pain","Management Drugs","Non-Opioids"],"articleSection":["Healthcare","Medical Devices and Technology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/","url":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/","name":"Chronic Pain Management: Path to USD 10 Billion and Opportunity","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/08\/Roots-Analysis-FeaturedImage-Pain.webp","datePublished":"2018-08-02T13:50:57+00:00","dateModified":"2026-03-30T08:10:46+00:00","description":"According to Roots Analysis, over 70 partnership agreements were inked between various players in the chronic pain management market.","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/08\/Roots-Analysis-FeaturedImage-Pain.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/08\/Roots-Analysis-FeaturedImage-Pain.webp","width":150,"height":102,"caption":"This is a feature image for blog article Non-Opioids Chronic Pain Management at Roots Analysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/non-opioids-chronic-pain-management-drugs-and-devices-future-roadmap-to-usd-10-billion-opportunity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Chronic Pain Management: Path to USD 10 Billion+ Opportunity"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62","name":"Arun Gupta","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","caption":"Arun Gupta"},"description":"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients."}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/9127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=9127"}],"version-history":[{"count":6,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/9127\/revisions"}],"predecessor-version":[{"id":22130,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/9127\/revisions\/22130"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/19178"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=9127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=9127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=9127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}